Trilobatin as an HIV‐1 entry inhibitor targeting the HIV‐1 Gp41 envelope
Open Access
- 26 May 2018
- journal article
- research article
- Published by Wiley in FEBS Letters
- Vol. 592 (13) , 2361-2377
Abstract
HIV‐1 transmembrane protein gp41 plays a crucial role by forming a stable six‐helix bundle during HIV entry. Due to highly conserved sequence of gp41, the development of an effective and safe small‐molecule compound targeting gp41 is a good choice. Currently, natural polyanionic ingredients with anti‐HIV activities have aroused concern. Here, we first discovered that a glycosylated dihydrochalcone, trilobatin, exhibited broad anti‐HIV‐1 activity and low cytotoxicity in vitro. Site‐directed mutagenesis analysis suggested that the hydrophobic residue (I564) located in gp41 pocket‐forming site is pivotal for anti‐HIV activity of trilobatin. Furthermore, trilobatin displayed synergistic anti‐HIV activities combined with other antiretroviral agents. Trilobatin has a good potential to be developed as a small‐molecule HIV‐1 entry inhibitor for clinical combination therapy.Keywords
Funding Information
- National Natural Science Foundation of China (81673481, 81773787, 81503116)
This publication has 44 references indexed in Scilit:
- Combinations of 3-Hydroxyphthalic Anhydride-Modified Ovalbumin With Antiretroviral Drug-Based Microbicide Candidates Display Synergistic and Complementary Effects Against HIV-1 InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2011
- Docking Validation Resources: Protein Family and Ligand Flexibility ExperimentsJournal of Chemical Information and Modeling, 2010
- Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV InfectionThe Journal of Infectious Diseases, 2010
- 3-Hydroxyphthalic Anhydride-Modified Chicken Ovalbumin Exhibits Potent and Broad Anti-HIV-1 Activity: a Potential Microbicide for Preventing Sexual Transmission of HIV-1Antimicrobial Agents and Chemotherapy, 2010
- Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV InfectionPLOS Medicine, 2008
- Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41Biochimica et Biophysica Acta (BBA) - General Subjects, 2005
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Fast, efficient generation of high‐quality atomic charges. AM1‐BCC model: II. Parameterization and validationJournal of Computational Chemistry, 2002
- A Salt Bridge between an N-terminal Coiled Coil of gp41 and an Antiviral Agent Targeted to the gp41 Core Is Important for Anti-HIV-1 ActivityBiochemical and Biophysical Research Communications, 2000
- A trimeric structural domain of the HIV-1 transmembrane glycoproteinNature Structural & Molecular Biology, 1995